25 studies found for:    " May 02, 2012":" June 01, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Unknown  A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV
Condition: HIV Dementia
Interventions: Drug: Long acting methylphenidate;   Drug: Matched placebo
2 Enrolling by invitation HIV Disclosure and Medication Adherence, a Pilot Study
Condition: HIV Infection
Intervention:
3 Active, not recruiting Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression
Condition: Human Immunodeficiency Virus
Intervention: Drug: Atazanavir, ritonavir, lamivudine
4 Completed A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: Maraviroc;   Drug: Combivir;   Drug: GSK2838510
5 Completed A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 Oral;   Drug: GSK1265744 LAP 800mg intramuscular injection;   Drug: GSK1265744 LAP 200mg subcutaneous injection;   Drug: GSK1265744 LAP 200mg intramuscular injection;   Drug: GSK1265744 LAP 400mg intramuscular injection;   Drug: TMC278 LA 1200mg intramuscular injection;   Drug: TMC278 LA 600mg intramuscular injection
6 Completed Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis
Conditions: HIV;   Tuberculosis
Interventions: Dietary Supplement: Protein calorie supplement;   Dietary Supplement: Micronutrient
7 Completed Outcomes for Antiretroviral Therapy Patients Receiving Palliative Care
Condition: HIV
Interventions: Other: Palliative care;   Other: Standard care
8 Withdrawn Pharmacokinetics, Pharmacodynamics and Cervicovaginal Lavage of Combined Oral Contraceptives and Raltegravir
Condition: HIV
Intervention:
9 Active, not recruiting Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIV
Condition: HIV/AIDS
Interventions: Behavioral: BCAP peer-driven intervention (PDI);   Behavioral: Control intervention
10 Recruiting Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)
Condition: HIV Dementia
Interventions: Drug: Atorvastatin (generic Lipitor);   Drug: placebo
11 Unknown  Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
Conditions: HIV Infection;   Pregnancy
Intervention:
12 Active, not recruiting Linking Infectious and Narcology Care in Russia
Conditions: HIV Infection;   Drug Use
Intervention: Behavioral: LINC Case Management
13 Recruiting Alcohol's Impact on Inflammatory Markers in HIV Disease - Russia ARCH Cohort
Conditions: HIV Infection;   Alcohol Use
Intervention:
14 Completed Evaluation of the Bioequivalence of a Combined Formulated Tablet
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg
15 Completed Enhancing HIV Risk Reduction Among Indian Women With Risky Husbands
Condition: Behavioral Risk for HIV
Intervention: Behavioral: RHANI WIves
16 Completed Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy
Condition: HIV-infection
Intervention: Drug: Darunavir/ritonavir
17 Active, not recruiting Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients
Condition: HIV-2 Infection
Intervention: Drug: emtricitabine / tenofovir disoproxil fumarate / raltegravir .
18 Withdrawn Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Optimized NRTI backbone
19 Active, not recruiting Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Conditions: Diabetic Retinopathy;   HIV
Interventions: Drug: Tesamorelin;   Drug: Placebo-Control
20 Recruiting Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV
Conditions: HIV Infection;   Tuberculosis
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Raltegravir;   Drug: Isoniazid;   Drug: Pyridoxine;   Drug: Pyrazinamide;   Drug: Ethambutol;   Drug: Rifabutin;   Drug: Rifampin

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Indicates status has not been verified in more than two years